Is it beneficial to give chemotherapy before surgery in patients with advanced ovarian cancer?

Not Applicable

Completed

• Conditions: Ovarian cancer; Cancer; Malignant neoplasm of ovary

• Registration Number: ISRCTN16064304
• Lead Sponsor: Cairo University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-07-31
• Study Start: 2020-10-02
• Last Update Posted: 19 October 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 56

Inclusion Criteria

Patients with locally advanced epithelial ovarian cancer

Exclusion Criteria

1. Patients with stage I and II tumors
2. Non-epithelial histology or borderline tumors
3. Underwent surgical interventions outside the trial institute

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Retrieved from operative notes in patient medical records at the end of patient stay:<br> 1. Operative time<br> 2. Procedure performed<br> 3. Need for blood transfusion<br> 4. Post operative complications<br>

Secondary Outcome Measures

Name	Time	Method
Progression free survival assessed using imaging and lab tests every 6 months up to 18 months